Brief Overview of the Late-Breaking Trials Presented at ACC’24: PART 2

In this second part of the Journal scan of this issue, we provide a brief overview of the late-breaking trials presented at the American College of Cardiology (ACC) Conference held in Atlanta, Georgia, from April 6 to 8, 2024, and their relevance to our daily clinical practice. The trials are categorized under the following headings: F. Lipidology (VICTORION INITIATE, SHASTA2, Liberate HR, Bridge-TIMI 73A, AEGIS II,) G. Artificial Intelligence (TACTic, Be Active, Tele ACS) H. Others (Deposition, Crescent, TACT2)